Of the less frequent molecular alterations of HCC, somatic mutations in NFE2L2 and KEAP1 are observed in 3–6% and 2–8% of HCCs, respectively [4,6]. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.